万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 英文名:
Rheumatoid Factor Stripper
- 保质期:
参照说明书
- 供应商:
北京博蕾德生物科技有限公司
- 保存条件:
参照说明书
| 类别 | 货号 | 名称 | 规格 | |
| 骨代谢系列 | BI-20492 | Sclerostin (SOST) ELISA | 人硬骨素ELISA试剂盒 | 1 Kit |
| BI-20413 | DKK-1 ELISA | 人DKK-1ELISA试剂盒 | 1 Kit | |
| BI-20432 | Cathepsin K ELISA Kit | 人组织蛋白酶K ELISA试剂盒 | 1 Kit | |
| BI-20403 | OPG ELISA | 人骨保护素ELISA试剂盒 | 1 Kit | |
| BI-20452 | sRANKL ELISA | 人游离型可溶性的Srankl ELISA试剂盒 | 1 Kit | |
| 心血管疾病 | BI-20742 | Endostatin ELISA | 人内皮抑制素ELISA试剂盒 | 1 Kit |
| BI-20082H | Big Endothelin-1 ELISA | 人大内皮素ELISA试剂盒 | 1 Kit | |
| BI-20052 | Endothelin ELISA | 人内皮素ELISA试剂盒 | 1 Kit | |
| BI-20872 | NT-proCNP ELISA | 人N-末端脑钠肽前体ELISA试剂盒 | 1 Kit | |
| BI-20852W | BNP Fragment ELISA | 人B型脑钠肽片段ELISA试剂盒 | 1 Kit | |
| SK-1204 | NT-proBNP ELISA | 人N-末端脑钠肽ELISA试剂盒 | 1 Kit | |
| BI-20892 | proANP ELISA | 人心钠肽前体ELISA试剂盒 | 1 Kit | |
| 动脉硬化 氧化应激 |
BI-20032 | Anti-Oxidized LDL (oLAB) ELISA | 抗氧化低密度脂蛋白ELSA试剂盒 | 1 Kit |
| BI-5007 | OxyStat Assay (Peroxides)ELISA | 1 Kit | ||
| BI-20022 | MDA-oxLDL ELISA | 1 Kit | ||
| 传染病 | BI-21032 | Borrelia lgG ELISA | 包柔氏螺旋体IgG ELISA试剂盒 | 1 Kit |
| BI-21042 | Borrelia lgM ELISA | 1 Kit | ||
| BI-3501 | Rheumatoid Factor Stripper | 1 Kit | ||
| 细胞增殖 | BI-5000 | EZ4U Cell Proliferation Assay |
1 Kit | |
| 抗体 | BI-RC4D | Polyclonal Anti-human C4d antibody | 200ul | |
| BI-RC4D-FITC | Polyclonal Anti-human C4d FITC Antibody | 100 µl | ||
| BI-RC4D-PE | Polyclonal Anti-human C4d PE Antibody | 50 µl |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Collagen-Induced Arthritis as a Model for Rheumatoid Arthritis
Collagen-induced arthritis (CIA) is an animal model of rheumatoid arthritis (RA) that is widely used to address questions of disease pathogenesis and to validate therapeutic targets. Arthritis is normally induced in mice or rats by immunization
Modeling the Effect of Susceptibility Factors (HLA and PTPN22) in Rheumatoid Arthritis
of a causative factor in a genomic region to its identification and the important task of estimating the disease risk due to it. The contrast between cases and controls may be used for the estimation of the genotype relative risks. However, the same population
Tumor Necrosis Factor as a Pharmacological Target
Tumor necrosis factor (TNF) was originally described as a molecule with antitumor properties released by macrophages stimulated with bacterial products. Almost at the same time that TNF was cloned, it was found to be identical to cachectin
技术资料暂无技术资料 索取技术资料





